Scarica l'app Stockscreener
5.77
2.45%
-0.145
Pre-mercato:
5.51
-0.26
-4.51%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Champions Oncology Inc Borsa (CSBR) Ultime notizie
Understanding Momentum Shifts in (CSBR) - Stock Traders Daily
Performance Recap: What is Champions Oncology Incs debt to equity ratioMarket Risk Summary & Community Trade Idea Sharing - baoquankhu1.vn
CSBR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Champions Oncology, Inc.Common Stock (NQ: CSBR - The Chronicle-Journal
Market Review: How correlated is Champions Oncology Inc to the S P5002026 Setups & Long-Term Capital Growth Strategies - baoquankhu1.vn
CSBR PE Ratio & Valuation, Is CSBR Overvalued - Intellectia AI
CSBR Should I Buy - Intellectia AI
Champions Oncology appoints Brian Alexander to board By Investing.com - Investing.com Australia
The World's First Agentic CMS Just Got Smarter: Kontent.ai Launches Expert Agents - Via Ritzau
Risk Off: How does Champions Oncology Inc compare to its peersLayoff News & Technical Pattern Based Buy Signals - baoquankhu1.vn
Champions Oncology Adds Director to Advance Data-Driven Strategy - TipRanks
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy - irw-press.com
Champ appoints Dr. Brian Alexander to board after Dr. Philip Breitfeld resignation - TradingView
Brian Alexander joins Champions Oncology (NASDAQ: CSBR) board - stocktitan.net
Stock Market Recap: Will Champions Oncology Inc benefit from geopolitical trends2026 Bull vs Bear & Safe Entry Momentum Tips - baoquankhu1.vn
Champions Oncology appoints Brian Alexander to board - Investing.com
Champions Oncology taps data-focused cancer doctor for board seat - stocktitan.net
Mandela Dollar ("MUSD") Announced to Promote Mandela's Legacy of Financial Inclusion for Underserved Communities Across the World - STT Info
Safe Staffing Requires New Models of Care, Not Just More Clinicians, Says Global Taskforce - STT Info
Champions Oncology, Inc. Appoints Brian Alexander to Board of Directors - marketscreener.com
MAIA PE Ratio & Valuation, Is MAIA Overvalued - Intellectia AI
Targets Report: Is Vinci Partners Investments Ltd a good ESG investment2026 Reactions & Verified Trade Idea Suggestions - baoquankhu1.vn
New Highs: Is Champions Oncology Inc showing insider buying2026 Fundamental Recap & Risk Controlled Daily Plans - baoquankhu1.vn
Valuation Update: Is Champions Oncology Inc stock trending bullishWeekly Stock Report & Risk Controlled Daily Plans - baoquankhu1.vn
Avoiding Lag: Real-Time Signals in (CSBR) Movement - Stock Traders Daily
Champions Oncology outlines full year revenue growth and positive adjusted EBITDA targets amid early traction in data business - MSN
IPO Launch: Is FOXXW stock undervalued right nowTrade Risk Assessment & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Strengthening Preclinical Packages for FDA Radiopharmaceutical Approval - PharmTech.com
Nasdaq Moves: What is the Moat Score of Champions Oncology Inc2026 Price Action Summary & Verified Chart Pattern Signals - baoquankhu1.vn
Trading Action: How does Champions Oncology Inc score in quality rankingsEarnings Risk Summary & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Nasdaq Moves: How correlated is Champions Oncology Inc to the S P5002026 Gainers & Low Volatility Stock Recommendations - baoquankhu1.vn
Guidance Update: Will Champions Oncology Inc benefit from geopolitical trends2026 Snapshot & Verified Entry Point Signals - baoquankhu1.vn
S P Trends: Is Champions Oncology Inc benefiting from innovation trendsMarket Risk Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn
Champions Oncology Inc (CSBR) Q3 2026 Earnings Call Highlights: Record Services Revenue and ... By GuruFocus - Investing.com Canada
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2026 earnings call transcript - MSN
Datavault AI Schedules Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026 - sttinfo.fi
Champions Oncology reports Q3 revenue of $16.6 million - Investing.com Nigeria
A activityTrade Risk Assessment & Verified Momentum Stock Watchlist - Mfd.ru
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2026 Earnings Call Transcript - Insider Monkey
Discipline and Rules-Based Execution in CSBR Response - Stock Traders Daily
Champions Oncology reports Q3 revenue of $16.6 million By Investing.com - Investing.com Australia
Champions Oncology (CSBR) Earnings Transcript - AOL.com
Champions Oncology (CSBR) Earnings Transcript - The Motley Fool
Champions Oncology, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Champions Oncology, Inc. Q3 2026 Financial Report: Balance Sheet, Income Statement, and Key Financial Highlights - Minichart
Earnings call transcript: Champions Oncology Q3 2026 misses EPS forecast, revenue grows - Investing.com
CSBR: Record core study revenue and positive adjusted EBITDA despite lower total revenue year-over-year - TradingView
Barco Announces HDR by Barco is confirmed as a format for THE DEVIL WEARS PRADA 2, THE MANDALORIAN AND GROGU, and TOY STORY 5 – NEWSnet Michigan - michigan.newsnetmedia.com
Champions Oncology earnings missed by $0.04, revenue topped estimates - Investing.com Canada
American Properties Realty, Inc. Leadership Attends NAHB International Builders’ Show in Florida - michigan.newsnetmedia.com
John Lauer, EVP and CCO, Announces Retirement Plans - michigan.newsnetmedia.com
Rising costs push Champions Oncology (NASDAQ: CSBR) from profit to loss - Stock Titan
CHAMPIONS ONCOLOGY ($CSBR) Releases Q3 2026 Earnings - Quiver Quantitative
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):